AngioSafe Leadership and Strategic Advisors
Backed by >200 additional years of engineering, clinical, nonclinical, manufacturing experience
- AngioSafe co-founder, investor, and Board Chairman
- Seasoned Silicon Valley investor, entrepreneur, global company builder
- President and CEO, Co-founder, Investor, Executive Board Member
- Built Pearl Therapeutics to a $1.15B acquisition by AstraZeneca
- Deep experience in drug and device combination field
- Founder, Head of Innovation at AngioSafe, Board Member
- General surgery, practicing endovascular physician
- A blend of interventional and engineering knowledge
- Executive VP, Regulatory, Quality and Clinical, Veranex Group.
- Deep global experience in device development regulatory affairs
- Overseeing AngioSafe regulatory, nonclinical, biostatistics and clinical strategy
- An internationally renowned corporate and health strategist
- Global strategy head, Samsung, Merck, Mckinsey
- An entrepreneur, company builder, advisor and mentor